SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-262958
Filing Date
2022-10-14
Accepted
2022-10-14 16:17:19
Documents
12
Period of Report
2022-10-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d382675d8k.htm   iXBRL 8-K 29890
  Complete submission text file 0001193125-22-262958.txt   154480

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20221014.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20221014_lab.xml EX-101.LAB 18740
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20221014_pre.xml EX-101.PRE 11704
6 EXTRACTED XBRL INSTANCE DOCUMENT d382675d8k_htm.xml XML 3458
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 221311545
SIC: 2836 Biological Products, (No Diagnostic Substances)